United States · FDA National Drug Code directory
Mavyret
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0074-2600_c1aa97e0-7350-4286-ac17-915bcdf0b08a
- Product NDC
- 0074-2600
- Form
- PELLET
- Composition / generic term
- Glecaprevir and Pibrentasvir
- Labeler
- AbbVie Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210610
- Source listing expiry
- 20271231
Source-listed ingredients
- PIBRENTASVIR — 20 mg/1
- GLECAPREVIR — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 PACKET in 1 CARTON (0074-2600-28) / 28 PELLET in 1 PACKET · 0074-2600-28
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →